Last reviewed · How we verify
NCT06686966
Prediction of Postoperative Complications and Survival in Gastric Cancer Using Preoperative Blood Markers
trial testing gastric cancer in Gastric Cancers in 3,400 participants. Completed in 1 November 2024.
1 November 2024
Quick facts
| Lead sponsor | First Affiliated Hospital of Chongqing Medical University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 3,400 |
| Start date | 1 January 2010 |
| Primary completion | 1 November 2024 |
| Estimated completion | 1 November 2024 |
Drugs / interventions tested
- gastric cancer
Conditions studied
- Gastric Cancers — all drugs for Gastric Cancers →
Sponsor
First Affiliated Hospital of Chongqing Medical University
Who can join
18 and older, any sex, with Gastric Cancers. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Gastric cancer is one of the most common cancers worldwide, especially in East Asia. Although surgery remains the main treatment, patients may experience postoperative complications and have varying long-term survival outcomes. Early identification of high-risk patients before surgery is important for improving treatment decisions and patient management. This study aims to develop a prediction model based on routinely available preoperative blood test results and clinical characteristics to estimate the risk of postoperative complications and long-term survival in patients with gastric cancer. The model will be developed and validated using data from multiple medical centers. By using easily accessible clinical information, this study seeks to provide a practical tool to help clinicians better assess patient risk before surgery, support personalized treatment planning, and improve overall patient outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06686966
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of gastric cancer
Trials testing the same drug.
- NCT06856382 — The Association Between Microplastics and Macrogenomics and Metabolomics in Gastric Cancer · active not recruiting
- NCT06854146 — The Effect of Environmental Factors on Gastric Cancer Based on Macrogenome · active not recruiting
Other recruiting trials for Gastric Cancers
Currently open trials in the same condition.
- NCT06766305 — QL1706 Combined With SOX Used in Theperioperative Treatment · Phase 1, PHASE2 · recruiting
- NCT07003334 — Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric Cancer · recruiting
- NCT06856382 — The Association Between Microplastics and Macrogenomics and Metabolomics in Gastric Cancer · active not recruiting
- NCT06895447 — Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy · Phase 2 · recruiting
- NCT06854146 — The Effect of Environmental Factors on Gastric Cancer Based on Macrogenome · active not recruiting
Other First Affiliated Hospital of Chongqing Medical University trials
Trials by the same sponsor.
- NCT07369713 — Efficacy and Safety of Accelerated Intermittent Theta-burst Stimulation (a-iTBS) in Adolescents With Depressive Disorder · NA · not yet recruiting
- NCT07499323 — Talquetamab in Patients With Refractory Generalized Myasthenia Gravis · NA · not yet recruiting
- NCT07409870 — An Integrated Multi-omics Study on the Molecular Mechanisms of Ureteral Stricture · not yet recruiting
- NCT07324473 — Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With Acquired R · Phase 2 · not yet recruiting
- NCT07203144 — Selenium Supplementation for Improving Depression in Children and Adolescents: Efficacy and Mechanistic Study · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06686966 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital of Chongqing Medical University
- Last refreshed: 3 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06686966.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing